AMGN: Amgen Inc - Full Company Report
Enter Ticker:
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
General Information
AMGEN INC
One Amgen Center Drivewww.amgen.com investor.relations@amgen.com
Industry
MED-BIOMED/GENE
Sector:
Medical
Fiscal Year End
December
Last Reported Quarter
09/30/09
Next EPS Date
01/25/2010
Price and Volume Information
Zacks Rank
Yesterday's Close
56.06
52 Week High
64.76
52 Week Low
44.96
Beta
0.53
20 Day Moving Average
7,596,209.50
Target Price Consensus
68.41
% Price Change
4 Week
-1.41
12 Week
-7.10
YTD
-4.10
% Price Change Relative to S&P 500
4 Week
-2.47
12 Week
-12.41
YTD
-20.63
Share Information
Shares Outstanding (millions)
1,015.48
Market Capitalization (millions)
56,237.12
Short Ratio
2.62
Last Split Date
11/22/1999
Dividend Information
Dividend Yield
0.00%
Annual Dividend
$0.00
Payout Ratio
0.00
Change in Payout Ratio
0.00
Last Dividend Payout / Amount
NA / $0.00
EPS Information
Current Quarter EPS Consensus Estimate
1.15
Current Year EPS Consensus Estimate
4.95
Estimated Long-Term EPS Growth Rate
10.80
Next EPS Report Date
01/25/2010
Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)
1.58
30 Days Ago
1.55
60 Days Ago
1.66
90 Days Ago
1.58
Fundamental Ratios
P/E
Current FY Estimate:
11.20
Trailing 12 Months:
11.35
PEG Ratio
1.04
EPS Growth
vs. Previous Year
23.14%
vs. Previous Quarter
17.32%
Sales Growth
vs. Previous Year
-1.63%
vs. Previous Quarter:
2.67%
Price Ratios
Price/Book
2.46
Price/Cash Flow
9.96
Price / Sales
3.86
ROE
09/30/09
23.82
06/30/09
23.56
03/31/09
24.06
ROA
09/30/09
13.11
06/30/09
12.84
03/31/09
12.90
Current Ratio
09/30/09
4.07
06/30/09
3.89
03/31/09
3.44
Quick Ratio
09/30/09
3.63
06/30/09
3.44
03/31/09
3.00
Operating Margin
09/30/09
34.53
06/30/09
32.79
03/31/09
32.22
Net Margin
09/30/09
36.22
06/30/09
35.60
03/31/09
34.32
Pre-Tax Margin
09/30/09
36.22
06/30/09
35.60
03/31/09
34.32
Book Value
09/30/09
22.51
06/30/09
21.10
03/31/09
19.55
Inventory Turnover
09/30/09
1.01
06/30/09
1.09
03/31/09
1.07
Debt-to-Equity
09/30/09
0.19
06/30/09
0.21
03/31/09
0.22
Debt to Capital
09/30/09
16.29
06/30/09
17.03
03/31/09
17.79
Sponsored Links 
-0.68